Search

Search Results
Results 18131 - 18140 of 18167 for breast cancer
  • Sudafed Sinus + Anti-inflammatory Pain Relief Caplets
    Drug - 13 May 2022
    Consumer Medicine Information (CMI) about Sudafed Sinus + Anti-inflammatory Pain Relief Caplets intended for persons living in Australia.
  • Dapa-Tabs
    Drug - 11 May 2022
    Consumer Medicine Information (CMI) about Dapa-Tabs (indapamide hemihydrate) intended for persons living in Australia.
  • Iscover
    Drug - 4 May 2022
    Consumer Medicine Information (CMI) about Iscover intended for persons living in Australia.
  • Clopidogrel Winthrop
    Drug - 4 May 2022
    Consumer Medicine Information (CMI) about Clopidogrel Winthrop intended for persons living in Australia.
  • Metomax
    Drug - 10 Dec 2021
    Consumer Medicine Information (CMI) about Metomax (paracetamol & metoclopramide hydrochloride) intended for persons living in Australia.
  • Hysone
    Drug - 28 Nov 2021
    Consumer Medicine Information (CMI) about Hysone intended for persons living in Australia.
  • Acnatac
    Drug - 18 Nov 2021
    Consumer Medicine Information (CMI) about Acnatac intended for persons living in Australia.
  • Tecfidera
    Drug - 6 Oct 2021
    Consumer Medicine Information (CMI) about Tecfidera (Dimethyl fumarate) intended for persons living in Australia.
  • Hygroton 25
    Drug - 20 Sep 2021
    Consumer Medicine Information (CMI) about Hygroton 25 (Chlortalidone) intended for persons living in Australia.
  • Toradol Injection
    Drug - 2 Sep 2021
    Consumer Medicine Information (CMI) about Toradol Injection intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback